Inspire Medical Systems Inc
NYSE:INSP

Watchlist Manager
Inspire Medical Systems Inc Logo
Inspire Medical Systems Inc
NYSE:INSP
Watchlist
Price: 187.58 USD -0.1% Market Closed
Market Cap: 5.6B USD
Have any thoughts about
Inspire Medical Systems Inc?
Write Note

Inspire Medical Systems Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inspire Medical Systems Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Inspire Medical Systems Inc
NYSE:INSP
Additional Paid In Capital
$1B
CAGR 3-Years
27%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Additional Paid In Capital
$2.2B
CAGR 3-Years
25%
CAGR 5-Years
26%
CAGR 10-Years
22%
Doximity Inc
NYSE:DOCS
Additional Paid In Capital
$823.9m
CAGR 3-Years
200%
CAGR 5-Years
138%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Additional Paid In Capital
$1.2B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Certara Inc
NASDAQ:CERT
Additional Paid In Capital
$1.2B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Additional Paid In Capital
$2.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inspire Medical Systems Inc
Glance View

Market Cap
5.6B USD
Industry
Health Care

Inspire Medical Systems Inc. emerged as a beacon of innovation in the medical technology landscape, carving a niche within the realm of obstructive sleep apnea (OSA) treatment. Founded with a vision to redefine the approach to sleep disorders, the company developed a breakthrough solution—a device that stimulates the hypoglossal nerve to maintain an open airway during sleep. This technology, known as Inspire therapy, represents a significant departure from traditional treatments like the cumbersome and often uncomfortable Continuous Positive Airway Pressure (CPAP) machines. By addressing the root cause of airway obstruction, Inspire provides an effective, less intrusive alternative, enhancing the overall quality of life for patients who struggle with conventional methods. Inspire Medical Systems makes money by marketing its implantable device primarily through a network of sleep centers and hospitals. The company operates in a business model that combines device sales with a supportive service infrastructure, ensuring that both healthcare providers and patients are well-acquainted with its innovative therapy. The revenue stream is fueled not only by the initial sales of the device but also through ongoing follow-ups and software updates necessary for optimal device functionality. By positioning itself at the intersection of customer care and cutting-edge technology, Inspire captures significant value in the growing OSA market, all while reinforcing its reputation as a leader in innovative medical solutions.

INSP Intrinsic Value
83.5 USD
Overvaluation 55%
Intrinsic Value
Price

See Also

What is Inspire Medical Systems Inc's Additional Paid In Capital?
Additional Paid In Capital
1B USD

Based on the financial report for Sep 30, 2024, Inspire Medical Systems Inc's Additional Paid In Capital amounts to 1B USD.

What is Inspire Medical Systems Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
26%

Over the last year, the Additional Paid In Capital growth was 13%. The average annual Additional Paid In Capital growth rates for Inspire Medical Systems Inc have been 27% over the past three years , 26% over the past five years .

Back to Top